First Participant Dosed in Study of BPL-003 Neurophysiological Effects
Investigators have dosed the first participant in a new study investigating the neurophysiological effects of BPL-003.
Source: psychiatrictimes.com
Beckley Psytech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Beckley Psytech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Beckley Psytech Today - Breaking & Trending Today
Mood Disorders in the News
The latest in mood disorder news, all in one place.
Source: psychiatrictimes.com
atai Life Sciences poised to create value as psychedelic therapies gain traction, analysts believe
Atai Life Sciences (NASDAQ:ATAI, ETR:9VC) has a pipeline of psychedelic and non-psychedelic drug assets that are poised to create value, analysts at...
Source: proactiveinvestors.com
Psychiatry Month in Review: March 2024
This March 2024 psychiatry month in review highlights positive phase 2b and phase 2a data for drugs targeting treatment-resistant depression, generalized anxiety disorder, and PTSD.
Source: hcplive.com